Emmanuelle Kempf

992 total citations
56 papers, 536 citations indexed

About

Emmanuelle Kempf is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Emmanuelle Kempf has authored 56 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Emmanuelle Kempf's work include COVID-19 and healthcare impacts (8 papers), Economic and Financial Impacts of Cancer (7 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Emmanuelle Kempf is often cited by papers focused on COVID-19 and healthcare impacts (8 papers), Economic and Financial Impacts of Cancer (7 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Emmanuelle Kempf collaborates with scholars based in France, Spain and United Kingdom. Emmanuelle Kempf's co-authors include Aranzazu González del Alba, Amparo Sánchez-Gastaldo, Ignacio Durán, Luis Paz‐Ares, Benjamin Besse, Benoı̂t Rousseau, Christophe Tournigand, Véronique Fournier, Gilles Châtellier and Guillaume Lamé and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Emmanuelle Kempf

51 papers receiving 526 citations

Peers

Emmanuelle Kempf
Josée-Lyne Ethier Canada
Pauline de Graeff Netherlands
JN Atkins United States
Nandini Menon India
Tyler F. Stewart United States
Katherine Enright Canada
Mary D. Chamberlin United States
Marina Chiara Garassino United States
Angela K. Green United States
Rogerio Lilenbaum United States
Josée-Lyne Ethier Canada
Emmanuelle Kempf
Citations per year, relative to Emmanuelle Kempf Emmanuelle Kempf (= 1×) peers Josée-Lyne Ethier

Countries citing papers authored by Emmanuelle Kempf

Since Specialization
Citations

This map shows the geographic impact of Emmanuelle Kempf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuelle Kempf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuelle Kempf more than expected).

Fields of papers citing papers by Emmanuelle Kempf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuelle Kempf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuelle Kempf. The network helps show where Emmanuelle Kempf may publish in the future.

Co-authorship network of co-authors of Emmanuelle Kempf

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuelle Kempf. A scholar is included among the top collaborators of Emmanuelle Kempf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuelle Kempf. Emmanuelle Kempf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barclay, Matthew, Ariel Cohen, Rémi Flicoteaux, et al.. (2025). Emergency cancer diagnosis in Paris: A cross‐sectional study using AP‐HP data. International Journal of Cancer. 157(11). 2283–2293. 1 indexed citations
2.
3.
4.
Berthelot, Emmanuelle, et al.. (2024). Collaborative and privacy-enhancing workflows on a clinical data warehouse: an example developing natural language processing pipelines to detect medical conditions. Journal of the American Medical Informatics Association. 31(6). 1280–1290. 5 indexed citations
5.
Rosa, A. La, Marc Cuggia, Christophe Tournigand, et al.. (2024). “The Truth Is, We Must Miss Some”: A Qualitative Study of the Patient Eligibility Screening Process, and Automation Perspectives, for Cancer Clinical Trials. Cancer Medicine. 13(23). e70466–e70466. 1 indexed citations
6.
Flicoteaux, Rémi, Guillaume Lamé, Romain Bey, et al.. (2023). Development of a natural language processing model for deriving breast cancer quality indicators : A cross-sectional, multicenter study. Revue d Épidémiologie et de Santé Publique. 71(6). 102189–102189. 2 indexed citations
7.
Lamé, Guillaume, Gilles Châtellier, Romain Bey, et al.. (2023). Why Are Data Missing in Clinical Data Warehouses? A Simulation Study of How Data Are Processed (and Can Be Lost). Studies in health technology and informatics. 302. 202–206. 1 indexed citations
8.
Lamé, Guillaume, Johanna Wassermann, Romain Bey, et al.. (2023). Impact of the COVID‐19 pandemic on clinical presentation, treatments, and outcomes of new breast cancer patients: A retrospective multicenter cohort study. Cancer Medicine. 12(22). 20918–20929. 4 indexed citations
9.
Hulin, Anne, Charlotte Fenioux, Emmanuelle Kempf, et al.. (2023). Pharmacology of Tyrosine Kinase Inhibitors. Clinical Journal of the American Society of Nephrology. 19(7). 927–938. 4 indexed citations
10.
Paillaud, Éléna, Philippe Caillet, Emmanuelle Kempf, et al.. (2023). Cancer mortality and competing causes of death in older adults with cancer: A prospective, multicentre cohort study (ELCAPA‐19). Cancer Medicine. 12(22). 20940–20952. 4 indexed citations
11.
Audureau, Étienne, Anaïs Pujals, Alain Luciani, et al.. (2023). Intentional R1 resection of liver metastases: A new treatment paradigm for patients with advanced colorectal cancer based on a propensity score–Matched case-control analysis. Clinics and Research in Hepatology and Gastroenterology. 47(4). 102097–102097. 2 indexed citations
12.
Boudou‐Rouquette, Pascaline, E. Martin, Emmanuelle Kempf, et al.. (2021). Rare bone sarcomas: A retrospective analysis of 145 adult patients from the French Sarcoma Group. International Journal of Cancer. 150(5). 825–836. 1 indexed citations
13.
Kempf, Emmanuelle, Guillaume Lamé, Richard Layese, et al.. (2021). New cancer cases at the time of SARS-Cov2 pandemic and related public health policies: A persistent and concerning decrease long after the end of the national lockdown. European Journal of Cancer. 150. 260–267. 31 indexed citations
14.
Tournigand, Christophe, et al.. (2020). Adverse events reporting in phase 3 oncology clinical trials of checkpoint inhibitors: A systematic review. Critical Reviews in Oncology/Hematology. 157. 103162–103162. 1 indexed citations
15.
Turpin, Anthony, Jean‐Marie Michot, Emmanuelle Kempf, et al.. (2017). Le lymphome de Hodgkin : stratégies thérapeutiques actuelles et futures. Bulletin du Cancer. 105(1). 81–98. 3 indexed citations
16.
Kempf, Emmanuelle, Benoı̂t Rousseau, Benjamin Besse, & Luis Paz‐Ares. (2016). KRASoncogene in lung cancer: focus on molecularly driven clinical trials. European Respiratory Review. 25(139). 71–76. 68 indexed citations
17.
Kempf, Emmanuelle, Anthony Turpin, Sophie Postel‐Vinay, et al.. (2016). A Case-Control Study Brings to Light the Causes of Screen Failures in Phase 1 Cancer Clinical Trials. PLoS ONE. 11(5). e0154895–e0154895. 9 indexed citations
18.
Kempf, Emmanuelle, G. Désaméricq, Cindy Neuzillet, et al.. (2016). First-line antiangiogenics for metastatic renal cell carcinoma: A systematic review and network meta-analysis. Critical Reviews in Oncology/Hematology. 107. 44–53. 21 indexed citations
19.
Kempf, Emmanuelle, Pierre Hirsch, Myriam Labopin, et al.. (2014). Prognosis of body mass index and chemotherapy dose capping in acute myeloid leukaemia. Leukemia Research. 38(12). 1425–1429. 11 indexed citations
20.
Sibler, Annie‐Paule, et al.. (1999). In vivo biotinylated recombinant antibodies: high efficiency of labelling and application to the cloning of active anti-human IgG1 Fab fragments. Journal of Immunological Methods. 224(1-2). 129–140. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Josée-Lyne Ethier Breakdown of academic impact, for papers by Pauline de Graeff Breakdown of academic impact, for papers by JN Atkins Breakdown of academic impact, for papers by Nandini Menon Breakdown of academic impact, for papers by Tyler F. Stewart Breakdown of academic impact, for papers by Katherine Enright Breakdown of academic impact, for papers by Mary D. Chamberlin Breakdown of academic impact, for papers by Marina Chiara Garassino Breakdown of academic impact, for papers by Angela K. Green Breakdown of academic impact, for papers by Rogerio Lilenbaum
Rankless by CCL
2026